Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates | Zendy

Simone Mok | Zendy; Margaret M. Hannan | Zendy; Lars Nölke | Zendy; Patrick J. Stapleton | Zendy; Niamh O’Sullivan | Zendy; Philip G. Murphy | Zendy; Anne Marie McLaughlin | Zendy; Eleanor McNamara | Zendy; Margaret Fitzgibbon | Zendy; Thomas R. Rogers | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates

Author(s) -

Simone Mok,

Margaret M. Hannan,

Lars Nölke,

Patrick J. Stapleton,

Niamh O’Sullivan,

Philip G. Murphy,

Anne Marie McLaughlin,

Eleanor McNamara,

Margaret Fitzgibbon,

Thomas R. Rogers

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00755-19

Subject(s) - antimicrobial , mycobacterium , biology , microbiology and biotechnology , bacteria , genetics

Mycobacterium chimaera is a slow-growing nontuberculousMycobacterium species belonging to theMycobacterium avium complex (MAC). It has been identified globally as the cause of a large outbreak of cardiovascular infections following open heart surgery, but it can also cause respiratory infections in individuals with underlying structural pulmonary disease. InvasiveM. chimaera infections are associated with poor clinical responses, and the optimal antibiotic treatment regimen for these infections is not known.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research